Under Rheumatoid Arthritis section from NICE Technology Appraisal Guideline published on June 2011
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs
Under Rheumatoid Arthritis section from NICE Technology Appraisal Guideline published on June 2011